June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Two novel non-coding base pair mutations at the same DNASE1 site as the original North Carolina Macular Dystrophy / MCDR1 locus affecting PRDM13, in two Korean families.
Author Affiliations & Notes
  • Leslie Small
    Molecular Insight Research Foundation, California, United States
  • Kent W Small
    Molecular Insight Research Foundation, California, United States
  • Amber Diaz
    Molecular Insight Research Foundation, California, United States
  • Kwangsic Joo
    Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Se Joon Woo
    Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Yuri Seo
    Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea (the Republic of)
  • Junwon Lee
    Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea (the Republic of)
  • Jinu Han
    Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Leslie Small None; Kent Small Molecular Insight Research Foundation, Code P (Patent); Amber Diaz None; Kwangsic Joo None; Se Joon Woo None; Yuri Seo None; Junwon Lee None; Jinu Han None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3652. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Leslie Small, Kent W Small, Amber Diaz, Kwangsic Joo, Se Joon Woo, Yuri Seo, Junwon Lee, Jinu Han; Two novel non-coding base pair mutations at the same DNASE1 site as the original North Carolina Macular Dystrophy / MCDR1 locus affecting PRDM13, in two Korean families.. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3652.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In East Asian, the causative variants in North Carolina Macular Dystrophy (NCMD) were rarely reported. Herein, we investigate molecular causes of NCMD in 2 Korean families.

Methods : Two Korean families with a diagnosis of NCMD were recruited from Yonsei University Severance Hospital and Seoul National University Bundang Hospital. Genome sequencing was performed, and small nucleotide variant and indel was called by DRAGEN-GATK best practice. Structural variant was assessed by ClinSV program. The genomic regions associated with NCMD encompassing PRDM13, IRX1, and its upstream regions were selected, and SNV and small indels were filtered based on gnomAD v.1.3.2 minor allele frequency (0.005%) and zygosity (heterozygous). Functional annotation of non-coding variant using DVAR, ncER, FATHMM-XF, and ReMM were used.

Results : Two Korean families with a diagnosis of NCMD were recruited from Yonsei University Severance Hospital and Seoul National University Bundang Hospital. Genome sequencing was performed, and small nucleotide variant and indel was called by DRAGEN-GATK best practice. Structural variant was assessed by ClinSV program. The genomic regions associated with NCMD encompassing PRDM13, IRX1, and its upstream regions were selected, and SNV and small indels were filtered based on gnomAD v.1.3.2 minor allele frequency (0.005%) and zygosity (heterozygous). Functional annotation of non-coding variant using DVAR, ncER, FATHMM-XF, and ReMM were used.

Conclusions : We identified two novel variants in NCMD in East Asians and provided further evidences in regulatory role in upstream region of PRDM13.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×